MEUD:LSE:LSE-Amundi Stoxx Europe 600 UCITS ETF C GBP (GBX)

ETF | Others |

Last Closing

USD 19589

Change

0.00 (0.00)%

Market Cap

N/A

Volume

4.41K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-4.05 (-1.47%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+12.50 (+6.43%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.28 (+2.25%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.10 (-0.70%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.30 (-1.66%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.47%)

USD 266.08B
0QZO:LSE 0QZO

-0.40 (-0.40%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.57 (-1.87%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

-2.36 (-1.41%)

USD 202.26B

ETFs Containing MEUD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.28% 37% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.28% 37% F 45% F
Trailing 12 Months  
Capital Gain 11.36% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.36% 44% F 48% F
Trailing 5 Years  
Capital Gain 37.25% 60% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.25% 60% D- 65% D
Average Annual (5 Year Horizon)  
Capital Gain 10.29% 65% D 68% D+
Dividend Return 10.29% 64% D 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.72% 64% D 79% B-
Risk Adjusted Return 96.01% 90% A- 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike